Salary:450000-550000 yuan/year
Experience requirements:3-10 years
Educational requirements:PhD
Job Description:
Job Introduction
Xellar Biosystems and City University of Hong Kong are jointly recruiting a postdoctoral fellow in the field of biological image analysis, who will primarily develop methods for analyzing cell images to promote drug development. This postdoctoral position is supported by the Hong Kong Innovation and Technology Fund. You can choose to work in Hong Kong/Shenzhen, Shanghai/Zhengzhou according to your personal preference
Job Responsibilities
? Develop characterization methods to extract features from multi-channel, 3D cell images to describe the therapeutic effects (efficacy, safety, and drug mechanism) on cells
? Develop generative models to generate images based on given biological or chemical information
? Develop methods for time series image analysis
? Exchange research results through publishing scientific papers or conference reports
Recruitment conditions
? Doctoral degrees in computer science, machine learning, artificial intelligence, biotechnology, computational biology, computational chemistry, or related fields
? Proficient in computer vision, image analysis, machine learning, and deep learning
? Proficient in Python programming and familiar with mainstream deep learning frameworks such as PyTorch, TensorFlow, or Jax)
? Those with experience in biological imaging, computational biology, or computational chemistry are preferred
? Strong written and oral communication skills
? Can independently conduct research projects and propose new research topics
Job benefits
? Salary and welfare benefits shall be implemented in accordance with the relevant regulations of HK ITC postdoctoral fellows, with an annual salary of HKD 540000
? Work closely with the team of Xellar Biosystems located in Boston, USA. Provide opportunities for communication and access
? Encourage and support participation in high-level international academic conferences
? Medical and Dental Insurance
? Paid annual leave
Unit Introduction
? The Multimedia Analysis (MA) Laboratory at City University of Hong Kong (CityU) is an interdisciplinary research group led by Dr. McCord. The research areas of this group focus on computational vision, computational photography, multimedia forensics and security, as well as biological image analysis
? Yaosu Technology was founded in Boston, USA at the end of 2021. It is a global "3D Wet AI" biotechnology startup that utilizes organ chips combined with high-dimensional 3D cell imaging, computer vision (CV), and artificial intelligence (AI) for drug discovery and precision medicine research, and has branches in the Asia Pacific region. Yaosu Technology is a pioneer in artificial intelligence driven biotechnology, utilizing the power of machine learning and human centered data to simplify the traditional tedious process of drug discovery. Our microfluidic 3D cell culture equipment simulates various organs and diseases, designed with efficiency in mind - integrating automation, scalability, and cost-effectiveness. This technology enables high content, high-resolution images to be fed into our computing and artificial intelligence pipelines, powering a powerful and highly predictive platform. Yaosu Technology is committed to redefining biotechnology, accelerating the journey of drug discovery, safety assessment, and personalized medicine
Guidance Teacher
? Dr. Xie Zhiyong is currently the Vice President of Yaosu Technology. Mainly responsible for building artificial intelligence and data science platforms, utilizing Yaosu Technology's organ chip data to improve understanding of diseases and evaluate drug efficacy. Before joining Yaosu Technology, Dr. Xie Zhiyong worked at Pfizer for 19 years, engaged in preclinical efficacy evaluation, clinical trials, drug safety, experimental design and management, data analysis, and AI applications. Dr. Xie Zhiyong obtained his Ph.D. and Master's degrees in Computer Science from Arizona State University and Peking University, respectively. And completed postdoctoral research at the University of Pennsylvania School of Medicine
? Dr. Bai Haiqing is the preclinical development director of Yaosu Technology. He has extensive experience in developing models based on human organ chips for disease modeling and drug testing. His work in these fields has been published in many * * journals. He has obtained multiple patent authorizations for his use of human organ chips for drug reuse. Dr. Bai led one of the first cases to submit preclinical data using human organ chips for IND. Dr. Bai holds a Bachelor of Science degree from the University of Science and Technology of China, a PhD in Pathology from the University of Rochester, and postdoctoral training from Harvard University
? Dr. Ma Kede is an assistant professor in the Department of Computer Science at City University of Hong Kong (CityU). He graduated from the University of Science and Technology of China (USTC) in 2012. Obtained master's and doctoral degrees from the University of Waterloo in 2014 and 2017, respectively. Before joining CityU, he served as a researcher at Howard Hughes Medical School and New York University from 2018 to 2019